InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Swirsky Douglas J, Director. Officer active across 2 companies, notably Cellectar Biosciences, Inc.. Aggregated, 6 disclosures have been published. Split: 2 buys · 2 sells. Total volume traded: €104k. Activity tracked since 14 September 2021. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Douglas J. Swirsky is a Board Member at Cellectar Biosciences, Inc. He plays an important role in overseeing the company's activities and developing its growth strategy.